pharma : Latest News, Videos and Photos | Outlook Business
Home » Search
Search Result : "pharma"

The pharma index has hugely underperformed the Sensex in CY17 owing to regulatory overhang and FDA issues 

Nilesh Shetty and Anand Shah on whether pharma stocks can make a comeback

By focusing on its strength in manufacturing lyophilized injectables, Gufic Biosciences has made a strong comeback and wants to aggressively push into the EU market next

When change sets in, companies initially live in denial, and when it catches up, it’s too late

Laurus Labs is crucially poised, as investors look forward to its R&D efforts finally paying off

After emerging as the global leader in the oral care segment, Essel Propack is betting on the non-oral space to sustain its growth momentum

Secret Diary of Ajay Piramal Part- 1

Even as the tax holiday comes to an end, businesses in Pantnagar say better infrastructure will drive future investments and sustain the growth momentum

Business is looking up in Nashik and Aurangabad, but labour issues — rising costs, shortage of skilled workers and unionisation — continue to play spoilsport

Even as the rest of the country grappled with GST, the Naroda cluster wasted no time in getting back on track 

Businesses across the country’s industrial clusters are optimistic about FY19

Neelesh Surana believes some pockets in the market are still cheap and one can expect an overall return of 13-15%

Betting on quality and structural themes is the key to Gautam Sinha Roy’s investing success

Unrelenting commitment towards process and sticking to his conviction have augured well for Invesco’s Taher Badshah

Sailesh Raj Bhan has made optimum use of cyclical downturns to deliver outperformance

Rising chronic illnesses and increasing health insurance coverage will spur domestic pharma industry growth

The Indian pharma industry has a stellar decadal run and it’s not going to change anytime soon

Banking on acquisitions, Torrent Pharma is focused on strengthening its presence in the domestic market

For Radhe Shyam Agarwal & Radhe Shyam Goenka, Emami still remains their best investment

Simulanis uses augmented and virtual reality with gamification to make training fun for students and employees

A strong product pipeline and receding US FDA threat could well turn the tide in favour of the beleaguered pharma players

While markets seem to be betting on a better-than expected earnings season, the numbers tell a different story

Lupin is betting on its specialty drugs business to counter the pricing pressures in the US generics market 

His bet on Natco Pharma’s differentiated product portfolio paid off while Monnet Ispat taught him to be wary of over-ambitious entrepreneurs

On Stands Now